Where does Hyper Ice, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hyper Ice, Inc. ranks #6,663 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hyper Ice, Inc. hold?

Hyper Ice, Inc. holds 50 US utility patents granted between 2016 and 2023, spanning 4 technology areas.

What is Hyper Ice, Inc.'s Innovation Score?

Hyper Ice, Inc. has an Innovation Score of 32.3 out of 100 (top 59% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Hyper Ice, Inc.'s patent grant rate increasing or decreasing?

Hyper Ice, Inc.'s recent grant velocity is +217% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Hyper Ice, Inc.'s patents?

Hyper Ice, Inc.'s patents average 5.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Hyper Ice, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Hyper Ice, Inc.

Q: What technology areas does Hyper Ice, Inc. focus on?

Hyper Ice, Inc.'s top technology area is A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY) with 15 patents. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 50 granted patents across 4 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hyper ranks #6,663 of 50,000 tracked US assignees by granted-patent volume, with 50 patents across 4 technology areas.

#6,663
of 50,000 US assignees by volume: Top 59%
by Innovation Score (32.3/100): 5.5
avg claims per patent: +217%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6663 · US Corporation #6,663 · 50 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 50 grants
UPPER-Q #6,663/50,000
PHOTO-FINISH HALOZYME
CPC-NARROW A61H · 4 areas
INNOV-THIN 32.3/100
CLAIMS-SPARSE 5.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +217% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Halozyme, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Ainsworth Game Techn… · near

32
Bechtel Hydrocarbon… · near

32
Clearwire IP Holding… · near

32
Hyper Ice · this assignee

32
Ipgreat Incorporated · near

32
3D Lighting Innovati… · lowest

7

What this shows Hyper Ice, Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-NARROW, INNOV-THIN, CLAIMS-SPARSE, TYPE-USCORP, VEL-SURGE, BOOK-FULL. Volume places it #6,663 of 50,000; Innovation Score 32.3/100 sits in the top 59% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Halozyme, Inc. (±0 grants).

Portfolio overview

Hyper Ice, Inc. has been granted 50 US utility patents between 2016 and 2023, placing Hyper Ice, Inc. at #6,663 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.5 claims per patent with primary concentration in A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). As a US Corporation, Hyper Ice, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Hyper sits between Halozyme, Inc. (50 patents, rank #6,659) and Keiwa Incorporated (50 patents, rank #6,667) - the closest US assignees by grant volume. The composite Innovation Score of 32.3/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 38 grants, compared with 12 in the 2015–2019 window, a +217% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Hyper Ice, Inc.'s 5.5 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 4 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Halozyme

50
Hitachi Industry…

50
Hoffman Enclosures

50
Humanetics

50
IPEX

50
June Life

50
Kamstrup A/S

50
Keiwa Incorporated

50
Hyper Ice ◀

50

What this shows Hyper holds 50 patents at rank #6,663, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hyper

By rank, the assignees closest to #6,663 in granted patent volume.

Leaders in A61H (Physical Therapy Apparatus)

Other assignees with the most granted patents in Hyper's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Hyper, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Clearwire IP Holdings L.l.c. 32 Ipgreat Incorporated 32 Ainsworth Game Technology Limited 32 Bechtel Hydrocarbon Technology Solutions, Inc. 32

Similar claim depth

Nearest assignees by average claims per patent (5.5 here).

Ninebot (beijing) TECH Co., Ltd. 5.5 avg Cknapp Sales, Inc. 5.5 avg Fujitsu General Limited 5.5 avg Gauthier Biomedical, Inc 5.5 avg

Hyper's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 Top 59% higher than 41% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Hyper Ice, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.0%
2018	4	8.0%
2019	7	14.0%
2020	5	10.0%
2021	8	16.0%
2022	19	38.0%
2023	6	12.0%

Which technologies does Hyper Ice, Inc. patent most?

A61H - PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY 15

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 5

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1

A63B - APPARATUS FOR PHYSICAL TRAINING, GYMNASTICS, SWIMMING, CLIMBING, OR FENCING; BALL GAMES; TRAINING EQUIPMENT 1

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#6,663

of 50,000 tracked assignees

Innovation Score

32.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.